{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:04:48Z","timestamp":1794546288579,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Henan Province Young and Middle-aged Health Science and Technology Innovation Talent Training Project","award":["YXKC2021010"],"award-info":[{"award-number":["YXKC2021010"]}]},{"name":"the Henan Province Young and Middle-aged Health Science and Technology Innovation Talent Training Project","award":["YXKC2021010"],"award-info":[{"award-number":["YXKC2021010"]}]},{"name":"the Henan Province Young and Middle-aged Health Science and Technology Innovation Talent Training Project","award":["YXKC2021010"],"award-info":[{"award-number":["YXKC2021010"]}]},{"name":"the Henan Province Young and Middle-aged Health Science and Technology Innovation Talent Training Project","award":["YXKC2021010"],"award-info":[{"award-number":["YXKC2021010"]}]},{"name":"the Henan Province Young and Middle-aged Health Science and Technology Innovation Talent Training Project","award":["YXKC2021010"],"award-info":[{"award-number":["YXKC2021010"]}]},{"name":"the Henan Province Young and Middle-aged Health Science and Technology Innovation Talent Training Project","award":["YXKC2021010"],"award-info":[{"award-number":["YXKC2021010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19293-z","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T16:35:58Z","timestamp":1765125358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The SREBF2-ACOT7 axis promotes tumor progression and predicts prognosis in diffuse large b-cell lymphoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Huan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianru","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"19293_CR1","doi-asserted-by":"publisher","first-page":"100397","DOI":"10.1016\/j.modpat.2023.100397","volume":"37","author":"S Loghavi","year":"2024","unstructured":"Loghavi, S. et al. Fifth edition of the world health classification of tumors of the hematopoietic and lymphoid tissue: myeloid neoplasms. Mod. Pathol. 37, 100397 (2024).","journal-title":"Mod. Pathol."},{"issue":"9","key":"19293_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn, L. H. & Salles, G. Diffuse large B-Cell Lymphoma[J]. N Engl. J. Med. 384 (9), 842\u2013858 (2021).","journal-title":"N Engl. J. Med."},{"issue":"19","key":"19293_CR3","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","volume":"24","author":"TM Habermann","year":"2006","unstructured":"Habermann, T. M. et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma[J]. J. Clin. Oncol. 24 (19), 3121\u20133127 (2006).","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"19293_CR4","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","volume":"12","author":"M Pfreundschuh","year":"2011","unstructured":"Pfreundschuh, M. et al. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera international trial (MInT) Group[J]. Lancet Oncol. 12 (11), 1013\u20131022 (2011).","journal-title":"Lancet Oncol."},{"issue":"12","key":"19293_CR5","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier, B. et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the groupe d\u2019etudes des lymphomes de l\u2019Adulte[J]. Blood 116 (12), 2040\u20132045 (2010).","journal-title":"Blood"},{"issue":"5","key":"19293_CR6","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1096\/fj.11-202853","volume":"26","author":"HW Kang","year":"2012","unstructured":"Kang, H. W. et al. Thioesterase superfamily member 2\/acyl-CoA thioesterase 13 (Them2\/Acot13) regulates hepatic lipid and glucose metabolism[J]. FASEB J. 26 (5), 2209\u20132221 (2012).","journal-title":"FASEB J."},{"issue":"14","key":"19293_CR7","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1073\/pnas.1116011109","volume":"109","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Targeted deletion of thioesterase superfamily member 1 promotes energy expenditure and protects against obesity and insulin resistance[J]. Proc. Natl. Acad. Sci. U S A. 109 (14), 5417\u20135422 (2012).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"14","key":"19293_CR8","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1128\/MCB.00312-12","volume":"32","author":"E Zhuravleva","year":"2012","unstructured":"Zhuravleva, E. et al. Acyl coenzyme A thioesterase Them5\/Acot15 is involved in Cardiolipin remodeling and fatty liver development[J]. Mol. Cell. Biol. 32 (14), 2685\u20132697 (2012).","journal-title":"Mol. Cell. Biol."},{"issue":"25","key":"19293_CR9","doi-asserted-by":"publisher","first-page":"10382","DOI":"10.1073\/pnas.0700974104","volume":"104","author":"JK Forwood","year":"2007","unstructured":"Forwood, J. K. et al. Structural basis for recruitment of tandem hotdog domains in acyl-CoA thioesterase 7 and its role in inflammation[J]. Proc. Natl. Acad. Sci. U S A. 104 (25), 10382\u201310387 (2007).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"19293_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12860-022-00450-5","volume":"24","author":"T Wang","year":"2023","unstructured":"Wang, T., Wang, K., Zhu, X. & Chen, N. ARNTL2 upregulation of ACOT7 promotes NSCLC cell proliferation through Inhibition of apoptosis and ferroptosis[J]. BMC Mol. Cell. Biol. 24 (1), 14 (2023).","journal-title":"BMC Mol. Cell. Biol."},{"key":"19293_CR11","doi-asserted-by":"crossref","unstructured":"Yin, X. et al. High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia[J]. J Healthc Eng, 23;2022:2669114. (2022).","DOI":"10.1155\/2022\/2669114"},{"key":"19293_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2020.09.022","volume":"498","author":"C Ni","year":"2021","unstructured":"Ni, C. et al. ACOT4 accumulation via AKT-mediated phosphorylation promotes pancreatic tumourigenesis[J]. Cancer Lett. 498, 19\u201330 (2021).","journal-title":"Cancer Lett."},{"key":"19293_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.humpath.2018.03.013","volume":"77","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. ACOT1 expression is associated with poor prognosis in gastric adenocarcinoma[J]. Hum. Pathol. 77, 35\u201344 (2018).","journal-title":"Hum. Pathol."},{"issue":"7","key":"19293_CR14","first-page":"2672","volume":"12","author":"Q Li","year":"2019","unstructured":"Li, Q. et al. The combined expressions of B7H4 and ACOT4 in cancer-associated fibroblasts are related to poor prognosis in patients with gastric carcinoma[J]. Int. J. Clin. Exp. Pathol. 12 (7), 2672\u20132681 (2019).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"19293_CR15","doi-asserted-by":"publisher","first-page":"594969","DOI":"10.3389\/fgene.2020.594969","volume":"11","author":"C Xu","year":"2020","unstructured":"Xu, C. et al. Acyl-CoA thioesterase 8 and 11 as novel biomarkers for clear cell renal cell Carcinoma[J]. Front. Genet. 11, 594969 (2020).","journal-title":"Front. Genet."},{"issue":"4","key":"19293_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3233\/CBM-182287","volume":"26","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Expression level of ACOT7 influences the prognosis in acute myeloid leukemia patients[J]. Cancer Biomark. 26 (4), 441\u2013449 (2019).","journal-title":"Cancer Biomark."},{"issue":"5","key":"19293_CR17","doi-asserted-by":"publisher","first-page":"e2793","DOI":"10.1038\/cddis.2017.202","volume":"8","author":"SH Jung","year":"2017","unstructured":"Jung, S. H. et al. Acyl-CoA thioesterase 7 is involved in cell cycle progression via regulation of PKC\u03b6-p53-p21 signaling pathway[J]. Cell. Death Dis. 8 (5), e2793 (2017).","journal-title":"Cell. Death Dis."},{"key":"19293_CR18","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2147\/JHC.S338353","volume":"8","author":"X Xie","year":"2021","unstructured":"Xie, X. et al. Acyl-CoA thioesterase 7 is transcriptionally activated by Kr\u00fcppel-Like factor 13 and promotes the progression of hepatocellular Carcinoma[J]. J. Hepatocell Carcinoma. 8, 1623\u20131641 (2021).","journal-title":"J. Hepatocell Carcinoma"},{"key":"19293_CR19","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"19293_CR20","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han, H. et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 46, D380\u2013D386 (2018).","journal-title":"Nucleic Acids Res."},{"key":"19293_CR21","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1128\/MCB.01548-12","volume":"33","author":"JM Ellis","year":"2013","unstructured":"Ellis, J. M., Wong, G. W. & Wolfgang, M. J. Acyl coenzyme A thioesterase 7 regulates neuronal fatty acid metabolism to prevent neurotoxicity. Mol. Cell. Biol. 33, 1869\u20131882 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"19293_CR22","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1194\/jlr.M015552","volume":"52","author":"M Cooke","year":"2011","unstructured":"Cooke, M. et al. Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4. J. Lipid Res. 52, 1936\u20131948 (2011).","journal-title":"J. Lipid Res."},{"key":"19293_CR23","doi-asserted-by":"publisher","first-page":"e2793","DOI":"10.1038\/cddis.2017.202","volume":"8","author":"SH Jung","year":"2017","unstructured":"Jung, S. H. et al. Acyl-CoA thioesterase 7 is involved in cell cycle progression via regulation of PKC\u03b6-p53-p21 signaling pathway. Cell Death Dis. 8, e2793 (2017).","journal-title":"Cell Death Dis."},{"key":"19293_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12860-022-00450-5","volume":"24","author":"T Wang","year":"2023","unstructured":"Wang, T., Wang, K., Zhu, X. & Chen, N. ARNTL2 upregulation of ACOT7 promotes NSCLC cell proliferation through Inhibition of apoptosis and ferroptosis. BMC Mol. Cell. Biology. 24, 14 (2023).","journal-title":"BMC Mol. Cell. Biology"},{"issue":"2","key":"19293_CR25","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/ijms25021109","volume":"25","author":"P Chandrasekaran","year":"2024","unstructured":"Chandrasekaran, P. & Weiskirchen, R. The role of SCAP\/SREBP as central regulators of lipid metabolism in hepatic Steatosis[J]. Int. J. Mol. Sci. 25 (2), 1109 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"19293_CR26","doi-asserted-by":"publisher","first-page":"1398921","DOI":"10.3389\/fimmu.2024.1398921","volume":"15","author":"X Xu","year":"2024","unstructured":"Xu, X., Jin, W., Chang, R. & Ding, X. Research progress of SREBP and its role in the pathogenesis of autoimmune rheumatic diseases[J]. Front. Immunol. 15, 1398921 (2024).","journal-title":"Front. Immunol."},{"issue":"11","key":"19293_CR27","doi-asserted-by":"publisher","first-page":"12869","DOI":"10.18632\/oncotarget.7331","volume":"7","author":"X Li","year":"2016","unstructured":"Li, X. et al. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer[J]. Oncotarget 7 (11), 12869\u201312884 (2016).","journal-title":"Oncotarget"},{"issue":"1","key":"19293_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbadis.2018.10.026","volume":"1865","author":"Z Jie","year":"2019","unstructured":"Jie, Z. et al. SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis[J]. Biochim. Biophys. Acta Mol. Basis Dis. 1865 (1), 115\u2013125 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"64","key":"19293_CR29","doi-asserted-by":"publisher","first-page":"108181","DOI":"10.18632\/oncotarget.22569","volume":"8","author":"S Armengol","year":"2017","unstructured":"Armengol, S. et al. SREBP-2-driven transcriptional activation of human SND1 oncogene[J]. Oncotarget 8 (64), 108181\u2013108194 (2017).","journal-title":"Oncotarget"},{"issue":"4","key":"19293_CR30","first-page":"3003","volume":"20","author":"C Zhong","year":"2019","unstructured":"Zhong, C., Fan, L., Li, Z., Yao, F. & Zhao, H. SREBP2 is upregulated in esophageal squamous cell carcinoma and cooperates with cMyc to regulate HMGCR expression[J]. Mol. Med. Rep. 20 (4), 3003\u20133010 (2019).","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"19293_CR31","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41467-019-09116-x","volume":"10","author":"SE Syafruddin","year":"2019","unstructured":"Syafruddin, S. E. et al. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma[J]. Nat. Commun. 10 (1), 1152 (2019).","journal-title":"Nat. Commun."},{"issue":"2","key":"19293_CR32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clnu.2023.12.005","volume":"43","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression[J]. Clin. Nutr. 43 (2), 332\u2013345 (2024).","journal-title":"Clin. Nutr."},{"issue":"11","key":"19293_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig, F. & Schulze, A. The multifaceted roles of fatty acid synthesis in cancer[J]. Nat. Rev. Cancer. 16 (11), 732\u2013749 (2016).","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"19293_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","volume":"20","author":"J Zhu","year":"2019","unstructured":"Zhu, J. & Thompson, C. B. Metabolic regulation of cell growth and proliferation[J]. Nat. Rev. Mol. Cell. Biol. 20 (7), 436\u2013450 (2019).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"20","key":"19293_CR35","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-08-1235","volume":"68","author":"T Migita","year":"2008","unstructured":"Migita, T. et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer[J]. Cancer Res. 68 (20), 8547\u20138554 (2008).","journal-title":"Cancer Res."},{"issue":"3","key":"19293_CR36","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","volume":"140","author":"DF Calvisi","year":"2011","unstructured":"Calvisi, D. F. et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma[J]. Gastroenterology 140 (3), 1071\u20131083 (2011).","journal-title":"Gastroenterology"},{"issue":"11","key":"19293_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrc.2016.87","volume":"16","author":"ZT Schug","year":"2016","unstructured":"Schug, Z. T., Vande Voorde, J. & Gottlieb, E. The metabolic fate of acetate in cancer[J]. Nat. Rev. Cancer. 16 (11), 708\u2013717 (2016).","journal-title":"Nat. Rev. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19293-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19293-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19293-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T10:37:19Z","timestamp":1765363039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19293-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19293"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19293-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0"}},{"value":"The studies were approved by Scientific Research and Clinical Trial Ethics Committee of the First Affiliated Hospital of Zhengzhou University (TZZU-LAC20240531[23]).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"43505"}}